To Listen
We have compiled a playlist from all our shows and podcasts on our network that discuss the current COVID-19 pandemic.
Products and Technology
FDA Issues EUA for Saline Oral Rinse COVID-19 RT-PCR Test from OralDNA® Labs
Access Genetics, LLC dba OralDNA® Labs (@OralDNA) announces that FDA has issued an amended Emergency Use Authorization for the OraRisk® COVID-19 RT-PCR test allowing testing from a saline oral rinse collection. This is the first Emergency Use Authorization for a simple saline 30 second swish and gargle collection. It eliminates the need for a nasal swab and avoids the difficulty some individuals have in providing sufficient saliva for saliva direct testing. Samples are viable for up to 72 hours and no longer require cold pack transportation.
Bronx-Based Elevator Manufacturer Creates New Technology to Fight COVID-19 and Prevent Other Pathogenic Spread in Elevators – Sterilyft
CEC Elevator Cab Corp. officially announced its latest innovative contribution to the elevator manufacturing business: Sterilyft (@sterilyft). Sterilyft is a completely unique elevator air filtration and sterilization system made in America to fight the current pandemic, and prevent future pathogenic spread. Sterilyft uses the germicidal power of UV-C light to kill pathogens, double MERV 13 filtering and then adding purified air back into the elevator cab space in a closed loop arrangement. CEC Elevator Cab Corp. manufactures Sterilyft in its Bronx-based facility, and has already installed the system in seven different states across the U.S., with plans to fill recent orders across the globe.
News and Noted
BrightTALK Partners with The Center for Health Affairs and CHAMPS Healthcare to Launch Global Healthcare Initiative
BrightTALK (@brighttalk), the virtual event platform that brings professionals and businesses together to learn and grow, in partnership with The Center for Health Affairs (@neohospitals) and CHAMPS, is launching the COVID-19 Leadership Series, a virtual initiative that delivers thought-provoking commentary and insights from a renowned group of global healthcare experts. The series begins on September 29 and will continue through 2021.
COVID-19 Study Retractions Drive Research Transparency Partnership and Push for Increased Publication of Negative/Null Findings
The Center for Biomedical Research Transparency, the American Heart Association (@American_Heart) and Wolters Kluwer join forces to launch a new Null Hypothesis collection for the AHA’s scientific journals portfolio. The importance of publishing research with negative results has been highlighted recently in the example of hydroxychloroquine as a treatment for novel coronavirus 2019 (COVID-19).
Strata Report Reveals COVID-19 Impact on U.S. Healthcare Delivery
A comprehensive six-month study of patient and procedure volume at 275 hospitals by Strata Decision Technology (@StrataDecision) revealed the significant financial and operational impact of the COVID-19 pandemic on the U.S. healthcare system.
Six U.S. states report record COVID hospitalizations, new restrictions in place
According to Reuters, six states reported record numbers of hospitalized COVID-19 patients, including Wisconsin, where officials on Tuesday issued a new order limiting the size of indoor public gatherings.
Vaccine News:
Early Results Show Moderna’s COVID Vaccine Safe, Effective in Older People
HealthDay reports that one of the big questions around any new COVID-19 vaccine is: Will it safely protect those at highest risk from the illness — older people? Now, the results of an early phase 1 trial in 40 adults over the age of 55 suggests that one vaccine, under development by drugmaker Moderna, elicits an immune system response that’s equal to that seen in younger recipients.
New FDA guidance on Covid-19 vaccine trials makes Election Day approval unlikely
NBC News reports that the Food and Drug Administration said Tuesday that manufacturers of Covid-19 vaccines will need to follow tens of thousands of study participants for at least two months to look for any possible safety issues before the agency would consider authorization. Given the timeline of when clinical trials began, the new guidance indicates that the earliest a Covid-19 vaccine might get an emergency use authorization would be the end of November — not Election Day, as President Donald Trump has previously touted.
Enough doses of COVID-19 vaccine could be made for U.S. by March to April: HHS
Reuters reports that enough doses of a coronavirus vaccine could be manufactured by March to April next year for every American who wants one, U.S. Health and Human Services Secretary Alex Azar said on Thursday.
To Read
Why COVID-19 Means More Value-Based Care by Geneia (@geneia) – There are reasons to believe one of the impacts of the COVID-19 pandemic will be more physicians choosing value-based care contracts.
COVID-19 ICU Patients Have High Risk of Clots, Research Shows by HealthDay News (@healthdayeditor) – Hospitalized COVID-19 patients face an increased risk of developing dangerous blood clots, a new review indicates.
The Northern Hemisphere Enters the Autumn of COVID-19 by hc1 (@hc1dotcom) – In a recent interview with Healthline, Dr. Peter J. Plantes was asked a number of questions about what lessons the United States can learn from the “second surge” of COVID-19 now occurring in Europe.
Back in the game by Kaiser Permanente (@aboutKP) – COVID-19 Return to Sports Playbook provides comprehensive guidance for returning to sports safely during the pandemic.
Latest from HHS:
Trump Administration Expands Collaboration with AstraZeneca to Develop and Manufacture an Investigational Monoclonal Antibody to Prevent COVID-19
Statement from Assistant Secretary for Health ADM Brett P. Giror: Update on Implementation of Resolution WHA73.1 on the COVID-19 Response
HHS Assistant Secretary for Health Admiral Brett Giroir to Participate in the World Health Organization Executive Board Special Session on COVID-19
HHS Teams Up with The Rockefeller Foundation to Share Best Practices for Increased COVID-19 Testing
Veklury (remdesivir) Now Available Directly from Distributor following Trump Administration’s Successful Allocations to States and U.S. Territories
Trump Administration Announces $20 Billion in New Phase 3 Provider Relief Funding
Events
Physicians’ Reciprocal Insurers (PRI)
What: COVID-19 Physician Peer Support
When: Mondays 8:00 p ET; Tuesdays & Thursdays 5:30 – 6:30 pm ET
Register for Monday Groups
Register for Tuesday & Thursday Groups
Twitter: @PRI_Insurance
COVID-19 Physician Peer Support – PRI has multiple weekly complimentary Virtual Support Groups on Coping with COVID-19 which your fellow physicians have been utilizing and finding great comfort and support from.
COVID-19 Resources
HealthcareNOW Radio rounded up some health IT resources being offered by companies to help healthcare professionals, American citizens and all of those affected in the fight against the coronavirus.
CDC is one of the major operating components of the Department of Health and Human Services. CDC works 24/7 to protect America from health, safety and security threats, both foreign and in the US. CDC increases the health security of our nation. As the nation’s health protection agency, CDC saves lives and protects people from health threats.
The CDC is the front line for our safety and information on the Coronavirus. Keep informed about COVID-19. Sign up to get emails or text alerts from the CDC.
Health Center COVID-19 Testing
Updated weekly using data from the Health Center COVID-19 Survey, the Health Center COVID-19 Testing Dashboard provides a high-level view of total COVID-19 tests conducted and the distribution of positive COVID-19 tests by race and ethnicity.